The effect of CFTR modulators on airway infection in cystic fibrosis

C Harvey, S Weldon, S Elborn, DG Downey… - International Journal of …, 2022 - mdpi.com
The advent of Cystic fibrosis transmembrane receptor (CFTR) modulators in 2012 was a
critical event in the history of cystic fibrosis (CF) treatment. Unlike traditional therapies that …

Role of inhaled antibiotics in the era of highly effective CFTR modulators

JS Elborn, F Blasi, PR Burgel… - European Respiratory …, 2023 - Eur Respiratory Soc
Recurrent and chronic bacterial infections are common in people with cystic fibrosis (CF)
and contribute to lung function decline. Antibiotics are the mainstay in the treatment of …

CFTR modulator therapies: potential impact on airway infections in cystic fibrosis

F Saluzzo, L Riberi, B Messore, NI Loré, I Esposito… - Cells, 2022 - mdpi.com
Cystic Fibrosis (CF) is an autosomal recessive disease caused by mutations in the gene
encoding for the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) protein …

Application of Quantile Discretization and Bayesian Network Analysis to Publicly Available Cystic Fibrosis Data Sets

KF Fukutani, TH Hampton, CA Bobak… - PACIFIC …, 2023 - World Scientific
The availability of multiple publicly-available datasets studying the same phenomenon has
the promise of accelerating scientific discovery. Meta-analysis can address issues of …

Gene expression responses of CF airway epithelial cells exposed to elexacaftor/tezacaftor/ivacaftor suggest benefits beyond improved CFTR channel function

TH Hampton, R Barnaby, C Roche… - … of Physiology-Lung …, 2024 - journals.physiology.org
The combination of elexacaftor/tezacaftor/ivacaftor (ETI, Trikafta) reverses the primary defect
in cystic fibrosis (CF) by improving CFTR-mediated Cl− and HCO3− secretion by airway …

Respiratory viruses and cystic fibrosis

K Brackenborough, H Ellis… - Seminars in Respiratory …, 2023 - thieme-connect.com
The threat of respiratory virus infection to human health and well-being has been clearly
highlighted by the coronavirus disease 2019 (COVID-19) pandemic. For people with cystic …

Gene expression responses of CF airway epithelial cells exposed to elexacaftor/tezacaftor/ivacaftor (ETI) suggest benefits beyond improved CFTR channel function

TH Hampton, R Barnaby, C Roche, A Nymon… - bioRxiv, 2024 - biorxiv.org
The combination of elexacaftor/tezacaftor/ivacaftor (ETI, Trikafta) reverses the primary defect
in Cystic Fibrosis (CF) by improving CFTR mediated Cl-and HCO3-secretion by airway …

O Impacto da Terapêutica Moduladora da CFTR na Infeção Pulmonar Crónica em Doentes com Fibrose Quística

J Rodrigues, R Boaventura… - Acta Médica …, 2023 - actamedicaportuguesa.com
Cystic fibrosis is the most common lethal genetic disease in the white population, affecting
approximately 80 000 people worldwide. It is an autosomal recessive, monogenic, and …

El papel de los antibióticos inhalados en la era de los moduladores de CFTR de alta eficacia.

JS Elborn, F Blasi, PR Burgel… - Kompass …, 2023 - search.ebscohost.com
Las infecciones bacterianas recurrentes y crónicas son frecuentes en pacientes con fibrosis
quística (FQ), y contribuyen al deterioro de la función pulmonar. Los antibióticos constituyen …

El papel de los antibióticos inhalados en la era de los moduladores de CFTR de alta eficacia

JS Elborn, F Blasi, PR Burgel, D Peckham - Kompass Neumología, 2023 - karger.com
Las infecciones bacterianas recurrentes y crónicas son frecuentes en pacientes con fibrosis
quística (FQ), y contribuyen al deterioro de la función pulmonar. Los antibióticos constituyen …